FDA warns of foot, leg amputations with J&J diabetes drug

Johnson & Johnson is required to add new warnings to its diabetes drug, Invokana, about the risk of foot and leg amputations, the U.S.

Johnson & Johnson is required to add new warnings to its diabetes drug, Invokana, about the risk of foot and leg amputations, the U.S.

Read more here:
FDA warns of foot, leg amputations with J&J diabetes drug